Overview
Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures
Status:
Completed
Completed
Trial end date:
2009-06-01
2009-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Evaluate the safety and efficacy of intranasal Clonazepam in subjects with epilepsy.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Jazz PharmaceuticalsTreatments:
Clonazepam
Criteria
Inclusion Criteria:- Diagnosis of refractory epilepsy
- No Nasal conditions that would preclude the use of intranasal product
Exclusion Criteria:
- Subject with a clinical significant unstable medical abnormality
- Subject currently or regularly taking Clonazepam